Molina Healthcare (MOH) Stock Forecast & Price Target

$294.73 +1.21 (+0.41%)

(As of 12/20/2024 05:31 PM ET)

Molina Healthcare - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 12 Analyst Ratings

Sell
1

Hold
6

Buy
5

Based on 12 Wall Street analysts who have issued ratings for Molina Healthcare in the last 12 months, the stock has a consensus rating of "Hold." Out of the 12 analysts, 1 has given a sell rating, 6 have given a hold rating, 4 have given a buy rating, and 1 has given a strong buy rating for MOH.

Consensus Price Target

$361.91
22.79% Upside

According to the 12 analysts' twelve-month price targets for Molina Healthcare, the average price target is $361.91. The highest price target for MOH is $439.00, while the lowest price target for MOH is $297.00. The average price target represents a forecasted upside of 22.79% from the current price of $294.73.

Get the Latest News and Ratings for MOH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Molina Healthcare and its competitors.

MOH Analyst Ratings Over Time

Type	Current Forecast 12/22/23 to 12/21/24	1 Month Ago 11/22/23 to 11/21/24	3 Months Ago 9/23/23 to 9/22/24	1 Year Ago 12/22/22 to 12/22/23
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	4 Buy rating(s)	5 Buy rating(s)	5 Buy rating(s)	6 Buy rating(s)
Hold	6 Hold rating(s)	6 Hold rating(s)	6 Hold rating(s)	2 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$361.91	$367.17	$378.00	$356.18
Forecasted Upside	22.79% Upside	24.01% Upside	7.56% Upside	-0.62% Downside
Consensus Rating	Hold	Hold	Hold	Moderate Buy

URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

MOH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

MOH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Molina Healthcare Stock vs. The Competition

Type	Molina Healthcare	Medical Companies	S&P 500
Consensus Rating Score	2.42	2.81	2.51
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	22.79% Upside	25,828.65% Upside	14.54% Upside
News Sentiment Rating	Positive News See Recent MOH News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
12/17/2024	JPMorgan Chase & Co. 3 of 5 stars		Reiterated Rating	Overweight ➝ Neutral	$378.00 ➝ $350.00	+18.42%
11/4/2024	Wells Fargo & Company 3 of 5 stars		Boost Target	Equal Weight ➝ Equal Weight	$360.00 ➝ $362.00	+10.70%
10/25/2024	Barclays 3 of 5 stars		Boost Target	Equal Weight ➝ Equal Weight	$359.00 ➝ $372.00	+12.74%
10/24/2024	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Overweight	$406.00 ➝ $406.00	+22.41%
10/24/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$405.00 ➝ $331.00	+20.48%
7/29/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Hold ➝ Hold	$354.00 ➝ $353.00	+6.02%
Get the Latest News and Ratings for MOH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Molina Healthcare and its competitors with MarketBeat's FREE daily newsletter.
7/25/2024	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Equal Weight ➝ Equal Weight	$320.00 ➝ $320.00	-1.32%
7/24/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Hold ➝ Hold	$354.00 ➝ $297.00	+2.86%
7/24/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$412.00 ➝ $351.00	+21.57%
7/15/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$440.00 ➝ $400.00	+36.52%
5/30/2024	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Ha Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
3/28/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Neutral ➝ Underperform	$439.00	+4.90%
12/21/2023	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$350.00 ➝ $380.00	+7.26%
7/14/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Overweight	$365.00	+21.87%
4/28/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$347.00 ➝ $350.00	+17.88%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 10:06 AM ET.

Should I Buy Molina Healthcare Stock? MOH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, December 12, 2024. Please send any questions or comments about these Molina Healthcare pros and cons to contact@marketbeat.com.

Molina Healthcare
Bull Case

Here are some ways that investors could benefit from investing in Molina Healthcare, Inc.:

The company recently reported a quarterly earnings per share (EPS) of $6.01, exceeding analysts' expectations of $5.96, indicating strong financial performance.
Molina Healthcare, Inc. achieved a revenue of $10.34 billion for the quarter, significantly higher than the anticipated $9.92 billion, showcasing robust growth.
The stock price is currently at $311.77, reflecting a 3.3% increase, which may indicate positive market sentiment and potential for further appreciation.
With a return on equity of 27.88%, the company demonstrates effective management and profitability, which can attract investors looking for strong returns.
The company operates in a stable sector, providing managed healthcare services to low-income families and individuals, which can offer resilience against economic downturns.

Molina Healthcare
Bear Case

Investors should be bearish about investing in Molina Healthcare, Inc. for these reasons:

The company has a relatively low net margin of 2.92%, which may indicate limited profitability compared to its revenue, potentially affecting long-term growth.
With a debt-to-equity ratio of 0.53, while manageable, it suggests that the company is using a moderate amount of debt to finance its operations, which could pose risks if market conditions change.
The stock has a beta of 0.54, indicating lower volatility compared to the market, which may limit potential high returns for investors seeking aggressive growth.
Analysts have set a consensus price target of $367.17, which suggests limited upside potential from the current stock price, potentially making it less attractive for short-term investors.
The company operates in a highly regulated industry, which can lead to uncertainties and challenges that may impact its operational efficiency and profitability.

MOH Forecast - Frequently Asked Questions

: According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for Molina Healthcare is $361.91, with a high forecast of $439.00 and a low forecast of $297.00.
: 12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Molina Healthcare in the last twelve months. There is currently 1 sell rating, 6 hold ratings, 4 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MOH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MOH, but not buy additional shares or sell existing shares.
: According to analysts, Molina Healthcare's stock has a predicted upside of 22.79% based on their 12-month stock forecasts.
: Molina Healthcare has been rated by research analysts at Barclays, Cantor Fitzgerald, JPMorgan Chase & Co., Robert W. Baird, and Wells Fargo & Company in the past 90 days.
: Analysts like Molina Healthcare less than other "medical" companies. The consensus rating for Molina Healthcare is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how MOH compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Could This Tiny Device Help You Make an Extra $30k a Year? (Ad)

I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.

Click here to see the details because I believe a lot of people will get rich.

This page (NYSE:MOH) was last updated on 12/21/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Molina Healthcare (MOH) Stock Forecast & Price Target